C4 Therapeutics Lands $73,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f631cfa5-5f7f-4ac4-8de0-a02fbc6d0a91
Date
1/8/2016
Company Name
C4 Therapeutics
Mailing Address
Undisclosed Cambridge, MA 10018 USA
Company Description
C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases.
Website
http://www.c4thera.com
Transaction Type
Venture Equity
Transaction Amount
$73,000,000
Transaction Round
Series A
Proceeds Purposes
The Company is developing novel treatments in the field of targeted protein degradation using proprietary Degronimid technology.
M&A Terms
Venture Investor
Cobro Ventures
Venture Investor
Cormorant Asset Management
Venture Investor
The Kraft Group